Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.

	March 31,
	2020		2019
	(In millions)
Cash and cash equivalents	$	2,365	$	3,224
Restricted cash and cash equivalents	58		74
Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows	$	2,423	$	3,298

Restricted Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.

	March 31,
	2020		2019
	(In millions)
Cash and cash equivalents	$	2,365	$	3,224
Restricted cash and cash equivalents	58		74
Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows	$	2,423	$	3,298

Amounts Due to Government Agencies

A summary of the categories of amounts due government agencies is as follows:

	March 31, 2020		December 31, 2019
	(In millions)
Medicaid program:
Medical cost floors and corridors	$	74	$	74
Other amounts due to states	76		84
Marketplace program:
Risk adjustment	456		368
Other	171		138
Total amounts due government agencies	$	777	$	664

Quality Incentive Premium Revenue Recognized

The following table quantifies the quality incentive premium revenue recognized for the periods presented, including the amounts earned in the periods presented and prior periods.

		Three Months Ended March 31,
		2020			2019
	(In millions)
Maximum available quality incentive premium - current period		$	61		$	45
Quality incentive premium revenue recognized in current period:
Earned current period		$	44		$	26
Earned prior periods		12			20
Total		$	56		46
Quality incentive premium revenue recognized as a percentage of total premium revenue		1.3		%	1.2		%

Schedule of receivables

	March 31, 2020		December 31, 2019
	(In millions)
Government receivables	$	1,167	$	1,056
Pharmacy rebate receivables	160		150
Health insurer fee reimbursement receivables	71		5
Other	205		195
Total	$	1,603	$	1,406